admin 
Lilly will hope that Foundayo continues to dominate and grow over Novo Nordisk in the obesity drug market. Credit: Michael Vi / Shutterstock.com. The US Food and Drug Administration (FDA) has approved Eli Lilly’s orforglipron pill for weight loss, ending Novo Nordisk’s first mover profits in the US after just three months. Oral glucagon-like peptide-1 … Read more
BIRMINGHAM, Ala. (WBRC) – Americans are now obsessed with protein, and nutritionists say there are several reasons for the surge. Protein-packed products now fill grocery store shelves. Instead of just protein bars and shakes, now there are protein pancakes, coffee, candy, and ice cream. “You can’t walk through a grocery store and not see the … Read more
The sports nutrition market is undergoing a major shift as consumers move away from single-benefit supplements toward multifunctional products that target a broader scope – spanning the gut-muscle axis, oxidative stress, and cognitive clarity. From dissolvable oral pouches to synergistic blends of creatine and magnesium, next-generation recovery aids prioritize high bioavailability and convenience for increasingly … Read more
Burning a large number of calories with each training session and competition, athletes, especially endurance athletes, are at risk of a deficiency or low energy availability, or LEA. LEA can be a relative lack of energy in sports, known as RED-S, where malnourished athletes often suffer injuries. A symptom for female athletes may be impaired … Read more
On March 30, 2026, Secretary of Health and Human Services Robert F. Kennedy, Jr., on the latest leg of his national Take Back Your Health tour, celebrated the hospital’s new commitments to strengthen nutrition-driven patient care by connecting a Florida farm directly to the hospital’s food system. Secretary Kennedy also announced that the Centers for … Read more
Foundayo, a new obesity pill made by Eli Lilly, was recently approved by the Food and Drug Administration. Eli Lilly hide caption caption letter Eli Lilly The Food and Drug Administration has approved a second GLP-1 pill to treat obesity, this time from drugmaker Eli Lilly. The new pill, Foundayo, is taken once a day … Read more
Item 1 of 2 The Zepbound injection pen, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. REUTERS/Brendan McDermid/ File Photo [1/2]Zepbound syringes, Eli Lilly’s weight loss drug, are displayed in New York City, U.S., December 11, 2023. REUTERS/Brendan McDermid/ File Photo Purchase Licensing RIGHTSopen a new tab April … Read more
If the number on the scale has gone down, it may not be for the reason you want. Most of the time, when you aim to lose weight, you may be looking for fat loss, or reduce excess body fat to change your appearance or improve your health and quality of life, says Dympna Gallagher, … Read more
4 minutes to read If it seems like new medications for weight loss are coming out at a fast rate, that’s because. The first GLP-1 oral pills became available earlier this year. Now, a new oral GLP-1 from drug company Eli Lilly—called Foundayo (orforglipron)—has just won FDA approval. Wajahat Mehal, MD, Medical Director of the … Read more
Across the Nation is a brief monthly rundown of news, links and quotes from the Church of Christ in the United States Have an idea for this column? Email Calvin Cockrell at [email protected]. Featured image (above): Ed Modicue, third from right, strikes a boxing pose with boys from Forsythe Church of Christ in Monroe, La. … Read more